Your browser doesn't support javascript.
loading
Genotyping lung cancer is an investment in the future.
Azzoli, Christopher G; Engelman, Jeffrey; Fidias, Panos; Gainor, Justin F; Heist, Rebecca S; Lamont, Elizabeth B; Lennes, Inga T; Rosovsky, Rachel P; Sequist, Lecia V; Shaw, Alice Tsang; Temel, Jennifer S.
Affiliation
  • Azzoli CG; Massachusetts General Hospital Cancer Center, Boston, MA cazzoli@partners.org.
  • Engelman J; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Fidias P; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Gainor JF; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Heist RS; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Lamont EB; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Lennes IT; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Rosovsky RP; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Sequist LV; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Shaw AT; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Temel JS; Massachusetts General Hospital Cancer Center, Boston, MA.
J Clin Oncol ; 32(31): 3576-7, 2014 Nov 01.
Article in En | MEDLINE | ID: mdl-25199750
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridines / Immunohistochemistry / Biomarkers, Tumor / Oncogene Proteins, Fusion / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: J Clin Oncol Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridines / Immunohistochemistry / Biomarkers, Tumor / Oncogene Proteins, Fusion / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: J Clin Oncol Year: 2014 Document type: Article